Navigation Links
Bell Ventures Launches Breakthrough Radical Defense Skin Care Ingredient
Date:12/8/2008

BOSTON, Dec. 8 /PRNewswire/ -- Bell Ventures LLC, a leader in innovative antioxidant solutions in food, nutrition, and skin care, announces the release of its new, high-performance natural ingredient, GlobalPAX(TM).

GlobalPAX(TM) is a proprietary extract made from the world's finest natural sources of proanthocyanidins (PACs), a powerful class of antioxidants. It is the first high-performance ingredient to standardize antioxidant capacity to Total ORAC, which analyzes antioxidant protection against 5 free radicals.

Bell Ventures also uses recognized markers of skin damage to demonstrate efficacy. GlobalPAX(TM) is standardized to collagenase and elastase inhibition, evidence that it helps defend against skin damage.

David Bell, President of Bell Ventures, says, "GlobalPAX(TM) is the result of our deep understanding of the science of antioxidants and our appreciation for their benefits to the skin. PACs are a very versatile antioxidant family, and we see this in the protection GlobalPAX(TM) delivers."

GlobalPAX(TM) provides powerful broad-spectrum defense against hydroxyl, peroxyl, peroxynitrite, singlet oxygen, and superoxide anion. Each of these radicals is implicated in skin damage.

The premium anti-aging skin care market is hungry for novel, high-performance naturals. The benefits of antioxidant protection provided by GlobalPAX(TM) make it ideal for differentiating next-generation products.

GlobalPAX(TM) has already received the attention of significant players in the industry. "We outperform a wide range of popular antioxidant ingredients, such as vitamin C, green tea extract, and green coffee cherry extract," Bell reports.

GlobalPAX(TM) can also be used to differentiate dietary supplements and the emerging category of inside-out skin care products and "beauty foods."

With standardized Total ORAC greater than 25,000 per gram, PACs, and skin outcome markers, GlobalPAX(TM) differentiates itself in a crowded market. As Bell says, "GlobalPAX(TM) lives up to its slogan, Prove what goes in before it goes on."

For more information call: 508-536-9511, email globalpax@bellventures.com, or visit http://www.globalpax.net


'/>"/>
SOURCE Bell Ventures LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Starfish Ventures Closes Australias Largest Venture Capital Fund With $185 Million Tech Fund
2. West Michigans Newest Medical Device Company Receives Support from the West Michigan Science & Technology Initiative and EDF Ventures
3. BIO Ventures for Global Health Receives $7 Million Grant from Gates Foundation to Engage Biotechnology in the Fight Against Neglected Diseases of the Developing World
4. Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing
5. MedAvante Closes $20 Million Financing by Goldman Sachs, Trevi Health Ventures
6. Oxford Finance Corporation and ATEL Ventures, Inc. Provide $7.5 Million Venture Loan to AxoGen, Inc.
7. SPO Medical Retains American Capital Ventures for Investor Relations Services
8. Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin(R)
9. The Bill & Melinda Gates Foundation, BIO, and Bio Ventures for Global Health Invite Proteome Systems CEO to Speak on TB Diagnostics Solutions At Partnering for Global Health Forum, Washington D.C.
10. Clarus Ventures Closes $660 Million Fund
11. 5AM Ventures Announces Expansion of Investment Team: Names Richard Ulevitch Venture Partner; Promotes Kevin Forrest and Andrew McMillan to Principal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... , Feb. 28, 2017  ITL Limited ... company, supplier and strategic partner that provides innovative ... individual health management, formally announces its rebrand to ... name change is part of the Company,s unified ... launch of an integrated corporate website, ITLHealthGroup.com ...
(Date:2/28/2017)... -- The Biotech industry is today,s focus on ... ZIOPHARM Oncology Inc. (NASDAQ: ZIOP ), Aurinia Pharmaceuticals ... ARNA ), and Marinus Pharmaceuticals Inc. (NASDAQ: ... which was narrowly mixed on Monday, February 27 th , ... 0.1%, while shares of health care companies in the S&P ...
(Date:2/27/2017)... , Feb. 27, 2017 AcelRx Pharmaceuticals, ... on the development and commercialization of innovative therapies ... today the U.S. Food and Drug Administration (FDA) ... under section 505(b)(2) for DSUVIA™ (formerly ARX-04) (sufentanil ... patients with moderate-to-severe acute pain in a medically ...
(Date:2/27/2017)... ... February 27, 2017 , ... In starting a program to hire college athletes, ... for attitude. Train for skill.” , In keeping with this philosophy, the Catalyst an ... salesman. Zamzow is hoping to replicate the practice throughout the company. , “I’ve heard ...
Breaking Biology Technology:
(Date:2/8/2017)... , Feb. 7, 2017 The biometrics ... by the confluence of organizations, desires to better ... knowledge-based systems (password and challenge questions), biometrics is ... government systems. The market is driven by use ... between consumer and enterprise uses cases, with consumer-facing ...
(Date:2/7/2017)... Minn. , Feb. 7, 2017   MedNet ... supports the entire spectrum of clinical research, is pleased ... iMedNet , its innovative, highly flexible and award ... iMedNet customers. iMedNet is a proven ... provides Electronic Data Capture (EDC), but also delivers an ...
(Date:2/7/2017)... 2017 Ipsidy Inc. ( www.ipsidy.com ... IDGS], ("Ipsidy" or the "Company") a provider of secure, ... is pleased to announce the following changes as part ... January 31, 2017, Philip D. Beck was ... President.  An experienced payment industry professional and public company ...
Breaking Biology News(10 mins):